SCHEMBL18481365

SCHEMBL18481365

CC(C)=C1C(=O)NC(=O)N(c2ccccc2)C1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGA4 P13612 5/20 0.51
▸ ITGB7 P26010 5/20 0.51
▸ MAPT P10636 11/20 0.47
▸ MEN1 O00255 9/20 0.47
▸ KMT2A Q03164 9/20 0.47
▸ ALDH1A1 P00352 7/20 0.47
▸ L3MBTL1 Q9Y468 3/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ POLB P06746 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ NTSR1 P30989 1/20 0.47
▸ GRK5 P34947 1/20 0.46
▸ TYRO3 Q06418 1/20 0.46
▸ DYRK1B Q9Y463 1/20 0.46
▸ GAA P10253 3/20 0.45
▸ HPGD P15428 4/20 0.45
▸ RECQL P46063 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11555543 0.80 ITGA4 (0.47) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL2080699 0.79 GRK5 (0.68) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL11798986 0.73 ITGA4 (0.43) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL11798981 0.73 ITGA4 (0.43) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL11093339 0.71 ITGA4 (0.43) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL11562341 0.70 ELANE (0.45) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL12220387 0.70 ALDH1A1 (0.53) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL18481366 0.69 ITGA4 (0.55) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL12220517 0.69 ALDH1A1 (0.45) MAPTMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL11713352 0.68 KDM4E (0.54) ITGA4ITGB7MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10265318-B2 Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi LEVINA ELIZABETH (US) 2019-04-23 — — US disclosed
US-20170035758-A1 Medicinal Drug with Activity against Gram Positive Bacteria, Mycobacteria and Fungi LEVINA ELIZABETH (US) 2017-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10265318-B2 Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi HRH4, HRH1, HRH2 ITGA4 3041/4885ITGB7 3595/4885MAPT 589/4885
US-20170035758-A1 Medicinal Drug with Activity against Gram Positive Bacteria, Mycobacteria and Fungi HRH4, HRH1, HRH2 ITGA4 3041/4885ITGB7 3595/4885MAPT 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback